drugset / Trial / NCT03683225
A Study to Evaluate in Patients With Parkinsonian Type Disorders
NaSingle-groupOpen-labelTreatment
Summary
A Phase 2 study to evaluate the safety, tolerability and initial efficacy of pramipexole ER, given with aprepitant in patients with parkinsonian type disorders
Timeline
- Start
- 2019-04-01
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | 80 mg | Oral |
| Subject | Pramipexole | Unknown | — | Oral |